Algert Global’s Ovid Therapeutics OVID Stock Holding History

Algert Global’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-37,490	Closed	-$112K	–	480
2020 Q1	$112K	Buy	37,490 +17,900	+91%	+$60.3K	0.05%	351
2019 Q4	$81K	Buy	+19,590	New	+$61.9K	0.02%	354

Other funds holding OVID

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Algert Global's OVID Position: Q2 2020 in Review

Algert Global sold out of Ovid Therapeutics (OVID) in Q2 2020, closing a stake of 37,490 shares — an estimated $112K sold.

Algert Global first reported a position in OVID in Q4 2019 and held it in 2 quarters. The position peaked at $112K in Q1 2020. 79 funds tracked by Wall St. Rank hold OVID as of Q2 2020.

Algert Global reported no remaining Ovid Therapeutics position as of Q2 2020 after selling out during the quarter.
Algert Global sold 37,490 Ovid Therapeutics shares in Q2 2020, an estimated $112K.
Algert Global first reported a position in Ovid Therapeutics in Q4 2019 and held it in 2 quarters.
Algert Global's Ovid Therapeutics position peaked at $112K in Q1 2020.
79 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2020.

Based on Algert Global's 13F filing for Q2 2020, filed 12 Aug 2020.